These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid. Villa J; Arana DM; Viedma E; Perez-Montarelo D; Chaves F Int J Med Microbiol; 2017 Sep; 307(6):340-345. PubMed ID: 28711315 [TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2. Arana DM; Ortega A; González-Barberá E; Lara N; Bautista V; Gómez-Ruíz D; Sáez D; Fernández-Romero S; Aracil B; Pérez-Vázquez M; Campos J; Oteo J; J Antimicrob Chemother; 2017 Dec; 72(12):3283-3287. PubMed ID: 29029114 [TBL] [Abstract][Full Text] [Related]
5. Coexistence of Qiao J; Chen Y; Ge H; Xu H; Guo X; Liu R; Li C; Chen R; Gou J; Chen M; Zheng B Front Microbiol; 2023; 14():1074612. PubMed ID: 37378293 [TBL] [Abstract][Full Text] [Related]
6. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J; Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200 [TBL] [Abstract][Full Text] [Related]
7. Detection of a clinical carbapenem-resistant Citrobacter portucalensis strain and the dissemination of C. portucalensis in clinical settings. Cao X; Xie H; Huang D; Zhou W; Liu Y; Shen H; Zhou K J Glob Antimicrob Resist; 2021 Dec; 27():79-81. PubMed ID: 34048980 [TBL] [Abstract][Full Text] [Related]
9. Emergence of Extensively Drug-Resistant ST170 Citrobacter portucalensis with Plasmids pK218-KPC, pK218-NDM, and pK218-SHV from a Tertiary Hospital, China. Luo X; Yu L; Feng J; Zhang J; Zheng C; Hu D; Dai P; Xu M; Li P; Lin R; Mu K Microbiol Spectr; 2022 Oct; 10(5):e0251022. PubMed ID: 36154205 [TBL] [Abstract][Full Text] [Related]
12. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey. Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514 [TBL] [Abstract][Full Text] [Related]
13. Genetic Characterization of Wang L; Li Z; Xiao N; Tang J; He Y; Guo J; Zhao X Infect Drug Resist; 2022; 15():2235-2242. PubMed ID: 35510156 [TBL] [Abstract][Full Text] [Related]
14. Genomic analysis of Citrobacter from Australian wastewater and silver gulls reveals novel sequence types carrying critically important antibiotic resistance genes. Hem S; Cummins ML; Wyrsch ER; Drigo B; Hoye BJ; Maute K; Sanderson-Smith M; Gorman J; Bogema DR; Jenkins C; Deutscher AT; Yam J; Hai F; Donner E; Jarocki VM; Djordjevic SP Sci Total Environ; 2024 Jan; 909():168608. PubMed ID: 37977387 [TBL] [Abstract][Full Text] [Related]
16. Carbapenemase-producing Gram-negative bacteria in hospital wastewater, wastewater treatment plants and surface waters in a metropolitan area in Germany, 2020. Hoffmann M; Fischer MA; Neumann B; Kiesewetter K; Hoffmann I; Werner G; Pfeifer Y; Lübbert C Sci Total Environ; 2023 Sep; 890():164179. PubMed ID: 37201847 [TBL] [Abstract][Full Text] [Related]
17. Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids. Riccobono E; Salvetti S; Coppi M; Montenora I; Di Pilato V; Rossolini GM J Antimicrob Chemother; 2023 Jul; 78(7):1677-1682. PubMed ID: 37207353 [TBL] [Abstract][Full Text] [Related]